09926.HK
Akeso, Inc.
HKSE · Healthcare · Biotechnology · CN
HKD 90.50
−0.28%Margins
Gross margin
76.0%
EBITDA margin
-24.2%
EBIT margin
-22.4%
Net margin
-28.0%
FCF margin
-25.0%
-11.2%
Return on equity
-5.9%
Return on assets
-5.6%
Return on invested capital
0.21x
Asset turnover
-HKD 655.6M
Cash from operations
HKD 12
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026